title: Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
authors.affiliation: Ophthalmology Section, Department of Plastic Surgery, Box 443, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. besmaeli@mdanderson.org
authors.forename: Bita
authors.initials: B
authors.lastname: Esmaeli
authors.forename: James L
authors.initials: JL
authors.lastname: Murray
authors.forename: M Amir
authors.initials: MA
authors.lastname: Ahmadi
authors.forename: Aresu
authors.initials: A
authors.lastname: Naderi
authors.forename: Sanjay
authors.initials: S
authors.lastname: Singh
authors.forename: Jorge
authors.initials: J
authors.lastname: Romaguera
authors.forename: Christine A
authors.initials: CA
authors.lastname: White
authors.forename: Peter
authors.initials: P
authors.lastname: McLaughlin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D015021:Yttrium Radioisotopes; D000069283:Rituximab; C422802:ibritumomab tiuxetan